Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase‐R)

BACKGROUND. Pharmacotherapy is generally recommended to treat patients with delirium. We sought to describe the current practice, effectiveness, and adverse effects of pharmacotherapy for hypoactive delirium in patients with advanced cancer, and to explore predictors of the deterioration of delirium...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Okuyama, Toru, Yoshiuchi, Kazuhiro, Ogawa, Asao, Iwase, Satoru, Yokomichi, Naosuke, Sakashita, Akihiro, Tagami, Keita, Uemura, Keiichi, Nakahara, Rika, Akechi, Tatsuo
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656448/
https://ncbi.nlm.nih.gov/pubmed/30610009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0242
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados